Skip to content

Totally Laparoscopic Distal Gastrectomy for Gastric Cancer

Randomized Controlled Trial Comparing the Outcomes of Totally Laparoscopic Distal Gastrectomy and Laparoscopy-assisted Gastrectomy for Gastric Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05556980
Acronym
TLDG
Enrollment
120
Registered
2022-09-27
Start date
2021-09-01
Completion date
2023-12-31
Last updated
2024-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Complications

Keywords

laparoscopy-assisted gastrectomy, totally laparoscopic gastrectomy, distal gastroectomy, postoperative hospital stay, survival, complications

Brief summary

This study was designed as a randomized clinical trial comparing the totally laparoscopic distal gastrectomy with laparoscopy-assisted distal gastroectomy for patients with gastric cancer, in terms of short-term and long-term outcomes.

Detailed description

When one patient was enrolled, he will be randomly divided into experimental group (totally laparoscopic distal gastrectomy) or control group (laparoscopy-assisted distal gastrectomy). When he receives surgery, intraoperative parameters would be recorded. when the patient discharges, the routine follow-up would be regularly performed for the survival.

Interventions

all the surgical procedure would be finished under laparoscopy

Sponsors

Liu Liu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

the Outcomes Assessor would not know which approach the patient received.

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* aged 18-80 years old, no gender limitation; * primary gastric cancer and planed for distal gastrectomy;

Exclusion criteria

* patients with total or proximal gastrectomy; * patients with distant metastasis.

Design outcomes

Primary

MeasureTime frameDescription
postoperative stayabout one week to one month from the finish of surgerythe time from the finish of surgery to discharge

Secondary

MeasureTime frameDescription
Survival3 yearthe survival rate at the third year from the finish of surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026